Healthcare Industry News: immune globulin
News Release - August 11, 2008
Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & MarketingMIAMI, Aug. 11 (HSMN NewsFeed) -- Novis Pharmaceuticals, a leading distributor of biotherapeutic products to healthcare providers, announced today that John W. Kilgour has been named Executive Vice President of Sales and Marketing. John is a healthcare professional with thirty-five years of business and management experience in both pharmaceutical and medical/surgical supply chain distribution.
Recently retired from Cardinal Health, John held positions of increasing responsibility for more than 35 years and most recently served as Vice President of Sales in Cardinal's Pharmaceutical Supply Chain Program. Primary responsibilities included sales to Integrated Delivery Networks (IDNs) and particular emphasis on resource leadership, coaching and developing Cardinal's related sales groups. Other key positions within Cardinal Health included sales management to national and regional Group Purchasing Organizations (GPOs) as well as managing pharmaceutical and medical supply sales and marketing initiatives for the acute care and managed care business segments.
Tom Burke, President and CEO of Novis Pharmaceuticals, said, "John will be a great mentor and teacher for our employees and an even better advocate for our customers. He has established longstanding, solid relationships and has a reputation of going the extra mile for clients, employees, and especially patients. His knowledge of the industry is second to none and we consider ourselves very fortunate to have him as part of the Novis team."
"I am excited to be here," added John Kilgour. "I am very impressed with Novis' core competencies and the really exceptional people who work here. This is a talented, enthusiastic and energetic group dedicated to exceeding customer expectations while meeting important patient need. Simply stated, the 'customer relationship' and 'dedication to patient need' is paramount in all that we do."
"This is a very challenging time in our industry," he continued. "Healthcare Providers are facing increasingly complex and more challenging disease states. Novis' product scope, its reliability for authenticity and pedigree tracking competencies are consistent with new important patient safety industry initiatives.
Novis Pharmaceuticals is committed to providing extraordinary service to their customers and patients and provides time-sensitive, life-saving medications nationwide, 24 hours a day - 7 days a week.
For more information about Novis Pharmaceuticals, please visit www.novispharma.com .
About NOVIS Pharmaceuticals
Novis Pharmaceuticals is a leading national distributor of some of the world's leading plasma-derived products such as albumin, immune globulin, hyperimmunes and anti-hemophilic Factors VII, VIII and IX. Hospitals, home infusion therapy companies and other healthcare providers use these biotherapeutics to treat trauma, autoimmune conditions, immune deficiencies, infectious diseases, bleeding disorders, and other life-threatening conditions.
Source: Novis Pharmaceuticals
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.